An asymmetric centromeric nucleosome
Abstract
Nucleosomes contain two copies of each core histone, held together by a naturally symmetric, homodimeric histone H3-H3 interface. This symmetry has complicated efforts to determine the regulatory potential of this architecture. Through molecular design and in vivo selection, we recently generated obligately heterodimeric H3s, providing a powerful tool for discovery of the degree to which nucleosome symmetry regulates chromosomal functions in living cells (Ichikawa et al., 2017). We now have extended this tool to the centromeric H3 isoform (Cse4/CENP-A) in budding yeast. These studies indicate that a single Cse4 N- or C-terminal extension per pair of Cse4 molecules is sufficient for kinetochore function, and validate previous experiments indicating that an octameric centromeric nucleosome is required for viability in this organism. These data also support the generality of the H3 asymmetric interface for probing general questions in chromatin biology.
https://doi.org/10.7554/eLife.37911.001Introduction
The histone octamer is comprised of two copies of each of the four core histones H2A, H2B, H3, and H4, organized with two H2A/H2B dimers associated with a central core tetramer of histone H3 and H4 (Kornberg and Lorch, 1999; Kornberg and Thomas, 1974). The presence of two copies of each histone in the octamer (Luger et al., 1997) raises the potential for three distinct stoichiometries (0, 1 or 2) for any modification, and increasing evidence supports the existence of asymmetrically-modified nucleosomes (Li and Shogren-Knaak, 2008; 2009; Voigt et al., 2012). Using rational design, followed by in vivo optimization and selection, we recently developed a pair of H3 proteins – H3X and H3Y – that form obligate heterodimers (Ichikawa et al., 2017). Shortly thereafter, another group reported an asymmetric H3 interface (H3D and H3H) based on an electrostatic interaction between a single altered amino acid on each half of the heterodimeric pair (Zhou et al., 2017). These systems were used to probe the biological outcomes resulting from packaging of the genome with nucleosomes bearing single or double point mutations, and the findings in the two studies display many similarities. For example, both studies showed that a single H3 N-terminal tail carrying H3K36me3 is sufficient to suppress cryptic transcriptional initiation. Thus, asymmetric nucleosome systems represent a novel approach to mechanistically probe the role of histone stoichiometry in multiple aspects of chromatin biology.
Histone isoforms are an important source of chromatin diversity. Notably, there is a specialized H3 isoform termed CENP-A (or Cse4 in budding yeast) required for centromere function (Foltz et al., 2006; Meluh et al., 1998; Stoler et al., 1995; Sullivan, 2001). Here, we extended the utility of our asymmetric H3 interface to explore the stoichiometry of Cse4 domains required for centromeric nucleosome function. The question of Cse4 stoichiometry has received particular attention (reviewed in [Biggins, 2013]). Octomeric Cse4 nucleosomes, with two copies of Cse4 in place of H3 can be reconstituted from recombinant components in vitro (Camahort et al., 2009; Dechassa et al., 2011; Kingston et al., 2011) and display a canonical nucleosome-like structure when analyzed at high resolution via X-ray crystallography (Sekulic et al., 2010). Microscopy-based experiments (Aravamudhan et al., 2013; Wisniewski et al., 2014) have also been consistent with octomeric Cse4 nucleosomes. However, crosslinking and atomic force microscopy studies (Dalal et al., 2007), reconstitution experiments (Furuyama et al., 2013), and chromatin digestion experiments (Henikoff et al., 2014) had suggested that Cse4/CENP-A forms a tetrameric half-nucleosome, raising the question of which mode of Cse4 interaction is important for chromosome segregation. Using our tools, we confirm that an octomeric centromeric nucleosome exists and is essential for viability in budding yeast, and show that important residues on both the N- and C-terminal Cse4 tails function when present at one copy per pair.
Results and discussion
All eukaryotes use a specialized histone H3 variant (CENP-A, or Cse4 in budding yeast) to form centromeric nucleosomes. CENP-A proteins are essential because they provide the fundamental attachment between chromosomes and kinetochore proteins, thereby ensuring equal chromosome segregation at mitosis (Biggins, 2013; Buchwitz et al., 1999; Meluh et al., 1998; Palmer et al., 1987; Stoler et al., 1995). Cse4/CENP-A proteins have a histone-fold globular domain similar to that of H3, with more divergent N- and C-terminal extensions (Chen et al., 2000; Keith et al., 1999; Tachiwana et al., 2011). To explore the stoichiometry of domains required for Cse4 function, we have generated a heterodimeric ‘Cse4X’ and ‘Cse4Y’ pair (Figure 1A).
We first attempted to place the X and Y asymmetric mutations we had developed in the canonical H3 protein onto wild-type Cse4. However, these constructs (termed Cse4X’ and Y’) would not support viability in the absence of a functional, homodimeric Cse4 protein (Chen et al., 2000) (Figure 1—figure supplement 1). We reasoned that the X and Y alterations may function only in the context of the canonical H3-H3 interface. Because the asymmetric Y alterations are present in both the α2 and α3 helices of the histone fold domain (Ichikawa et al., 2017; Figure 1A), we tested the X and Y alterations in a chimeric Cse4 in which key residues in these helices were substituted with canonical H3 residues. We used a chimeric Cse4 (‘Chimera’ in Figure 1A; originally termed the cse4-337 allele (Keith et al., 1999) which had previously been shown to support viability (Keith et al., 1999); also see Figure 1B). Inserting the X and Y asymmetric residues into this Chimera, we generated the Cse4X and Cse4Y proteins (Figure 1A). Notably, cells simultaneously expressing Cse4X and Cse4Y were viable, but those expressing a single one of these alone were not (Figure 1B). These data support the idea that at least some of Cse4 functions are performed as part of an octameric centromeric nucleosome, consistent with previous structural, biochemical and cell biological studies (Aravamudhan et al., 2013; Black and Cleveland, 2011; Camahort et al., 2009; Dechassa et al., 2011; Kingston et al., 2011; Wisniewski et al., 2014; Xiao et al., 2017; Zhang et al., 2012). Further, these data suggested that the centromeric H3 isoform is amenable to analysis via our asymmetric mutations.
We note that the Chimera protein itself conferred a partial temperature-sensitive growth phenotype, in which colony size was markedly reduced at 37°C, but much less so at 34°C (Figure 1C). Adding the X and Y alterations to the Chimera protein very modestly increased temperature sensitivity at 37°C, but did not increase the sensitivity of the cells to benomyl, a microtubule destabilizing drug (Davidse and Flach, 1977). To test whether an alternative protein design could provide a less perturbed setting for these studies, we compared the X-Y interface to a different pair of asymmetric H3 constructs (Zhou et al., 2017) that were described soon after our study was published. That study tested pairs of oppositely charged electrostatic residues at key contact points between nucleosomal H3 molecules, finding one pair of asymmetric H3s that would support viability. This pair is comprised of ‘H3D’, which contains an A110D replacement, and ‘H3H’, which contains a L130H replacement. We generated Cse4 derivatives with either the D or H single amino acid substitutions (Figure 1—figure supplement 2, Cse4D’ and Cse4H’), and we also made D or H substitutions in the context of the Chimera used above (Figure 1—figure supplement 2, Cse4D and Cse4H). Notably, we found that after removing homodimeric Cse4, cells expressing either the Cse4H’ or the Cse4H protein without any partner protein were viable and grew robustly, indicating significant homodimerization of this protein (Figure 1—figure supplement 2B). This led us to test the reported D-H interface in the context of canonical histone H3. We observed that H3H would also support growth of cells lacking all other sources of histone H3, although growth was faster when both H and D were present (Figure 1—figure supplement 3). In contrast, as we had observed before (Ichikawa et al., 2017), no growth of cells expressing only H3X or H3Y was observed. Not only do our findings imply significant H3H homodimerization in vivo, but we find no improvement in temperature sensitivity in the D-H system, as cells expressing H3D + H3H were also unable to grow at 37°C (Figure 1—figure supplement 4). We therefore performed all subsequent experiments on Cse4 heterodimerization using the Cse4X and Cse4Y pair.
We also tested for heterodimerization of Cse4X and Cse4Y via biochemical experiments. To do this, we expressed three distinct epitope-tagged X or Y proteins simultaneously in the same cell, and used co-immunoprecipitation to analyze dimerization. We had taken a similar approach in the analysis of H3 (Ichikawa et al., 2017). In the present case, the poor solubility of the Cse4 nucleosome (Skene and Henikoff, 2017) led us to use a different protocol for the preparation of cell extracts. Specifically, we modified existing protocols and generated high-concentration MNase-treated extracts (Furuyama and Biggins, 2007; Ichikawa et al., 2014; Nelson and Fangman, 1979) as the starting point for immunoprecipitation. Upon anti-FLAG epitope immunoprecipitation, we easily detected the expected heterodimeric interactions (i.e. HA-Cse4Y with FLAG-Cse4X in strain PKY5527 cells and V5-Cse4X with FLAG-Cse4Y in PKY5529 cells) but not homodimeric interactions (Figure 1—figure supplement 5). Together, our genetic experiments (Figure 1B) and the co-immunoprecipitation experiments (Figure 1—figure supplement 5) led us to conclude that we had designed a specific heterodimeric Cse4X-Cse4Y nucleosome.
We next used our asymmetric proteins to analyze Cse4 domain structure. The long N-terminal tail of Cse4 contains an Essential N-terminal Domain (END) between residues 28 and 60 (Chen et al., 2000; Keith et al., 1999, Figure 2A), which is a binding site for the Ctf19-Mcm21-Okp1 ‘COMA’ kinetochore protein complex (Chen et al., 2000). Complete removal of the END domain via deletion of the N-terminal 70 residues of homodimeric, wild-type Cse4 generated a protein (Cse4 Δ70) that does not support viability (Figure 2B), consistent with previous observations (Chen et al., 2000; Keith et al., 1999). The END domain was also essential in the context of the Cse4 X-Y system, as cells expressing paired Cse4 proteins containing the Δ70 deletion on both X and Y were also inviable. In contrast, cells with one intact END domain on either Cse4X or Cse4Y were viable. To further assess the key biological function of the centromeric nucleosome, we measured centromeric plasmid maintenance, which depends on a cloned centromeric sequence (CEN; [Murray and Szostak, 1983]). CEN is the binding site for the Cse4 nucleosome, and is thereby essential for kinetochore-mediated chromosome segregation (Camahort et al., 2009; Meluh et al., 1998); reviewed in [Biggins, 2013]). We observed that cells with a single END-Cse4 construct displayed plasmid loss rates that were statistically indistinguishable from those observed in the presence of the ‘pseudo-wildtype’ Cse4 X + Y pair (Figure 3). These data indicate that a single END domain per Cse4 nucleosome is sufficient for building functional kinetochores. However, these cells displayed partial temperature sensitivity at 34°C and sensitivity to benomyl, suggesting that this architecture is suboptimal under stress conditions (Figure 2C). These data confirm that asymmetric Cse4 proteins, like asymmetric H3 proteins, can be used to probe domain stoichiometry in living cells.
Next, we analyzed motifs at the Cse4 C-terminus. The terminal three residues of Cse4, QFI, are distinct from the ERS residues at the end of H3 (Figure 4A), and comprise part of the interaction surface for the centromeric protein CENP-C (Mif2 in budding yeast; (Kato et al., 2013), which is critical for kinetochore function (Meeks-Wagner et al., 1986; Przewloka et al., 2011). We first exchanged ERS residues onto the C-termini of the homodimeric Chimera Cse4 protein and onto the heterodimeric Cse4X and Cse4Y constructs (Figure 4A). We observed that cells remained viable in the absence of QFI residues, consistent with previous studies (Keith et al., 1999). However, cells expressing only Cse4 proteins with ERS C-termini (e.g. the Chimera-ERS and X-ERS +Y ERS strains) displayed slow growth at 30°C and extreme sensitivity to elevated temperatures or benomyl (Figure 4B). X-ERS +Y ERS cells also displayed significantly elevated plasmid loss rates compared to the Cse4 X + Y pseudo-wildtype cells (Figure 3). In contrast, X-ERS +Y and X + Y ERS strains with a single ERS domain per Cse4 nucleosome did not display temperature or benomyl sensitivity (Figure 4B) or elevated plasmid loss rates (Figure 3). Thus, our asymmetric Cse4 tools allowed us to conclude that a single QFI tail per Cse4 nucleosome was sufficient to maintain normal centromere function and prevent stress sensitivity phenotypes.
Recent experiments indicate that in addition to the C-terminus, unique residues within Cse4 Loop1, between the α1 and α2 alpha helices of the histone fold domain, are required for optimal Mif2 binding to Cse4 (Xiao et al., 2017). Therefore, we investigated how Loop1 mutations synergize with ERS substitutions in our asymmetric system. Notably, Loop1 in Cse4 is three residues longer than in H3, with an insertion of residues KDQ, and there is also a substitution of an evolutionarily conserved H3 phenylalanine for a tryptophan residue (Figure 4—figure supplement 1A). Previous studies have shown that simultaneous deletion of the KDQ residues and conversion of the W to an F residue is tolerated, but results in a ~ five fold increase in chromosome loss rates (Keith et al., 1999). In our experiments, combination of the Loop1 and ERS mutations (termed ERS*) in the context of Cse4-Chimera resulted in lethality, as did the presence of the ERS* combination on both halves of the X + Y asymmetric pair (Figure 4—figure supplement 1B). In contrast, the combined ERS* mutations could support viability if present only on a single half of the asymmetric Cse4 pair, although there was an increase in plasmid instability, temperature sensitivity and benomyl sensitivity in these strains (Figure 3, Figure 4—figure supplement 1C). These data are consistent with our earlier conclusion that a single intact Mif2 binding site per centromeric nucleosome is sufficient for viability.
We also tested the effects of combining a single N-terminal deletion (Δ70) and a single set of ERS* substitutions in cis or trans configurations within the asymmetric Cse4 nucleosome (Figure 4—figure supplement 2). Viable cells in both the cis and trans mutants could be obtained in the initial selection against the plasmid encoding homodimeric Cse4 (Figure 4—figure supplement 2A). We note that the two ‘trans’ mutant combinations may produce FOA-resistant colonies at different frequencies, perhaps because of combining the X mutations in alpha helix 3 with the C-terminal ERS mutations in the same molecule. In contrast to any small differences between the trans strains, the major observation was that none of the cis or trans strains could be propagated for further analysis (Figure 4—figure supplement 2B). These results suggest that simultaneous removal of one interaction site for the COMA complex at the Cse4 N-terminus and one interaction site for CENP-C at the Cse4 C-terminus resulted in a highly compromised Cse4 nucleosome. In other words, a single wild-type N-terminus and C-terminus per Cse4 nucleosome appears insufficient to prevent lethal levels of genome instability.
Additionally, because some of our altered Cse4 proteins were affecting viability and plasmid stability, we wondered if the asymmetric interface was undergoing sufficient negative selection during the course of these experiments to select for revertants different from the input constructs. To test for this, we amplified the CSE4 genes from the indicated strains listed in Supplementary file 1 (Figure 4—figure supplement 3). In no case did we observe alterations from the input plasmid sequence. We conclude that the phenotypes observed throughout this work result from the designed constructs and not due to intragenic suppressor mutations in CSE4.
In summary, we show here that our asymmetric nucleosome technology is well-suited to explore histone H3 variants. In analogy to our H3 studies, these reagents can be used to study Cse4 modifications, for example S33 phosphorylation (Hoffmann et al., 2018), K37 methylation (Samel et al., 2012) or phosphorylation by Ipl1 (aurora kinase) (Boeckmann et al., 2013). Of course, CENP-A stoichiometry and modification is also important in mammalian cells, but involves much more complex centromeres (Müller and Almouzni, 2017), and it will be of great interest to explore nucleosomal symmetry in those systems.
Materials and methods
Plasmid constructions and mutagenesis
Request a detailed protocolDNA fragments containing the CSE4/H3 chimera or Cse4X or Cse4Y mutants were synthesized as gBlocks Gene Fragments (Integrated DNA Technologies). To make plasmids containing cse4 mutants, the DNA fragments and linearized yeast CEN/ARS plasmids (pRS414 or pRS415, [Sikorski and Hieter, 1989]) were co-transformed into yeast strain YPH499. N-terminal deletion, L1 and ERS mutations were generated according to inverse PCR based site-directed mutagenesis protocol (Toyobo). DNA sequences of all cse4 mutant plasmids used in this study were confirmed with Sanger sequencing.
Yeast strains
Request a detailed protocolAll cse4 mutant strains (listed in Supplementary file 1) were derived from CSE4 ‘shuffle’ strain PKY2160, which has chromosomal CSE4-encoding locus deleted and carries the cse4-107 gene on a URA3-marked plasmid (Sharp et al., 2002). PKY2160 was transformed with the test plasmids according to a DMSO-modified version of a yeast LiOAc transformation method (Hill et al., 1991). Colonies were picked and streaked on selective media containing 5-FOA to select against the URA3 plasmid containing the cse4-107 gene.
Plate growth assays
Request a detailed protocolFor growth assay under high temperature or microtubule destabilization stresses, strains were grown overnight in 2 ml YPD medium at 30°C. Cultures were adjusted to OD600 = 0.6, and five-fold dilutions were spotted on YPD-agar plates or YPD-agar plates containing 10 μg/ml benomyl/0.2% DMSO. Plates were incubated at 30, 34 or 37°C for 2–3 days.
Mitotic plasmid stability assay
Request a detailed protocolThe plasmid loss rate was measured as described previously (Gibson et al., 1990) with minor modifications. Briefly, 2 ml YPD cultures were inoculated with fresh colonies picked from selective medium. The cultures were grown for approximately 10 generations. The samples were diluted with water and plated onto selective medium or nonselective medium (YPD). Percentages of plasmid-containing cells were determined from the ratio of colony numbers on selective medium divided by the numbers on nonselective medium. The plasmid loss rate was calculated with following formula:
N=log2(F/I)
Plasmid loss/generation = 1-(F/I)1/ N
I is the initial percentage of plasmid-containing cells and F is the final percentage of plasmid-containing cells after N generations in nonselective medium.
Plasmid resequencing
Request a detailed protocolDNA was purified from yeast strains as described (Hoffman and Winston, 1987). DNA was PCR-amplified with oligonucleotide OYI38 (GATATGATTTATCTTGATCCCACTGTGTCG) plus either OYI39 (ATTTAAGTATTGTTTGTGCACTTGCCTATG) to amplify the CSE4 gene on the TRP1 plasmid, or plus OYI40 (TGTGGATATACTAGAAGTTCTCCTCGACCG) to target the CSE4 gene on the LEU2 plasmid. PCR products were purified on Zymo Research Clean and Concentrate-5 columns and analyzed by Sanger DNA sequencing/capillary electrophoresis, using oligonucleotide OPK1597 (ATGACCTTATAATAACCTTATTTAAAACAT).
Biochemistry
Request a detailed protocolImmunoprecipitation of Cse4 nucleosomes was performed with yeast cells expressing 3xFLAG-Cse4X, 3xV5-Cse4X and 3xHA-Cse4Y (PKY5527), or 3xFLAG-Cse4Y, 3xV5-Cse4X and 3xHA-Cse4Y (PKY5529). Yeast nuclei preparation was performed as described previously (Furuyama and Biggins, 2007). The final pellet including nuclei was resuspended in digestion buffer (10 mM HEPES-NaOH (pH 7.5), 0.5 mM MgCl2, 0.05 mM CaCl2, 1 mM PMSF, 1.8 ml / g of wet cells)(Ichikawa et al., 2014). The nuclei were prewarmed at 37°C for 5 min, and then MNase (final 100 units/ml, Worthington Biochemicals) was added at 37°C for 10 min. Reactions were immediately stopped with 11 mM EDTA, and the nuclei were pelleted at 10,000 x g for 10 min at 4°C. The supernatant was recovered and mixed with equal volume of high salt buffer (50 mM HEPES-KOH (pH7.5), 500 mM NaCl, 1 mM EDTA, 1% Triton X-100) before immunoprecipitation. 1 ml of the resulting sample was incubated with 10 μl of anti-FLAG M2 affinity gel beads (Sigma-Aldrich) overnight at 4°C, and the beads were recovered and washed three times with the high salt buffer. Proteins were eluted by boiling in 2 x SDS-PAGE buffer (0.1 M Tris-HCl (pH 6.8), 2% SDS, 20% glycerol, 0.02% bromophenol blue, 1/50 vol of 2-mercaptoethanol). For immunoblotting, the eluted proteins were separated by electrophoresis on 10–20% gradient gels (FUJIFILM Wako Pure Chemical Corporation) and transferred onto a nitrocellulose membrane (Amersham Protran Premium 0.2 μm NC (GE Healthcare). The membrane was probed sequentially with the following primary antibodies: anti-HA (Sigma-Aldrich, 12013819001), anti-V5 (Abcam, ab9113) and anti-FLAG (Sigma-Aldrich, A8592). WB Stripping Solution (Nacalai Tesque, Inc.) was used to remove antibodies from the membrane between each probing step. The specific bands were detected with horseradish peroxidase-conjugated secondary antibodies in Chemi-Lumi One Ultra solution (Nacalai Tesque, Inc.), and the images were taken with Amersham Imager 600 (GE Healthcare).
Data availability
All data generated or analysed during this study are included in the manuscript and supporting files.
References
-
Phosphorylation of centromeric histone H3 variant regulates chromosome segregation in Saccharomyces cerevisiaeMolecular Biology of the Cell 24:2034–2044.https://doi.org/10.1091/mbc.e12-12-0893
-
Cse4 is part of an octameric nucleosome in budding yeastMolecular Cell 35:794–805.https://doi.org/10.1016/j.molcel.2009.07.022
-
The human CENP-A centromeric nucleosome-associated complexNature Cell Biology 8:458–469.https://doi.org/10.1038/ncb1397
-
Reconstitution of hemisomes on budding yeast centromeric DNANucleic Acids Research 41:5769–5783.https://doi.org/10.1093/nar/gkt314
-
The phenotype of the minichromosome maintenance mutant mcm3 is characteristic of mutants defective in DNA replicationMolecular and Cellular Biology 10:5707–5720.https://doi.org/10.1128/MCB.10.11.5707
-
DMSO-enhanced whole cell yeast transformationNucleic Acids Research 19:5791.https://doi.org/10.1093/nar/19.20.5791
-
Telomeric repeats act as nucleosome-disfavouring sequences in vivoNucleic Acids Research 42:1541–1552.https://doi.org/10.1093/nar/gkt1006
-
Analysis of primary structural determinants that distinguish the centromere-specific function of histone variant Cse4p from histone H3Molecular and Cellular Biology 19:6130–6139.https://doi.org/10.1128/MCB.19.9.6130
-
Biophysical characterization of the centromere-specific nucleosome from budding yeastJournal of Biological Chemistry 286:4021–4026.https://doi.org/10.1074/jbc.M110.189340
-
The Gcn5 bromodomain of the SAGA complex facilitates cooperative and cross-tail acetylation of nucleosomesJournal of Biological Chemistry 284:9411–9417.https://doi.org/10.1074/jbc.M809617200
-
Chromatin dynamics during the cell cycle at centromeresNature Reviews Genetics 18:192–208.https://doi.org/10.1038/nrg.2016.157
-
A 17-kD centromere protein (CENP-A) copurifies with nucleosome core particles and with histonesThe Journal of Cell Biology 104:805–815.https://doi.org/10.1083/jcb.104.4.805
-
CENP-C is a structural platform for kinetochore assemblyCurrent Biology 21:399–405.https://doi.org/10.1016/j.cub.2011.02.005
-
A system of shuttle vectors and yeast host strains designed for efficient manipulation of DNA in Saccharomyces cerevisiaeGenetics 122:19–27.
-
A solid foundation: functional specialization of centromeric chromatinCurrent Opinion in Genetics & Development 11:182–188.https://doi.org/10.1016/S0959-437X(00)00177-5
-
Molecular basis of CENP-C association with the CENP-A nucleosome at yeast centromeresGenes & Development 31:1958–1972.https://doi.org/10.1101/gad.304782.117
Article and author information
Author details
Funding
National Institutes of Health (R01GM100164)
- Paul D Kaufman
National Institutes of Health (R35GM127035)
- Paul D Kaufman
Japan Society for the Promotion of Science (JSPS KAKENHI 18H05531)
- Noriko Saitoh
The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
Acknowledgements
This work was supported by NIH grants R01GM100164 and R35GM127035 (PDK), and JSPS KAKENHI 18H05531 (NS). We thank Oliver Rando for insightful comments; Dr. Jin-Qiu Zhou for providing the histone shuffle strain LHT001; and Dr. Mitsuhiro Shimizu for his great help and precise advice about yeast nuclei preparation.
Copyright
© 2018, Ichikawa et al.
This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 2,081
- views
-
- 277
- downloads
-
- 6
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Further reading
-
- Chromosomes and Gene Expression
- Microbiology and Infectious Disease
Candida glabrata can thrive inside macrophages and tolerate high levels of azole antifungals. These innate abilities render infections by this human pathogen a clinical challenge. How C. glabrata reacts inside macrophages and what is the molecular basis of its drug tolerance are not well understood. Here, we mapped genome-wide RNA polymerase II (RNAPII) occupancy in C. glabrata to delineate its transcriptional responses during macrophage infection in high temporal resolution. RNAPII profiles revealed dynamic C. glabrata responses to macrophages with genes of specialized pathways activated chronologically at different times of infection. We identified an uncharacterized transcription factor (CgXbp1) important for the chronological macrophage response, survival in macrophages, and virulence. Genome-wide mapping of CgXbp1 direct targets further revealed its multi-faceted functions, regulating not only virulence-related genes but also genes associated with drug resistance. Finally, we showed that CgXbp1 indeed also affects fluconazole resistance. Overall, this work presents a powerful approach for examining host-pathogen interaction and uncovers a novel transcription factor important for C. glabrata’s survival in macrophages and drug tolerance.
-
- Chromosomes and Gene Expression
- Neuroscience
Pathogenic variants in subunits of RNA polymerase (Pol) III cause a spectrum of Polr3-related neurodegenerative diseases including 4H leukodystrophy. Disease onset occurs from infancy to early adulthood and is associated with a variable range and severity of neurological and non-neurological features. The molecular basis of Polr3-related disease pathogenesis is unknown. We developed a postnatal whole-body mouse model expressing pathogenic Polr3a mutations to examine the molecular mechanisms by which reduced Pol III transcription results primarily in central nervous system phenotypes. Polr3a mutant mice exhibit behavioral deficits, cerebral pathology and exocrine pancreatic atrophy. Transcriptome and immunohistochemistry analyses of cerebra during disease progression show a reduction in most Pol III transcripts, induction of innate immune and integrated stress responses and cell-type-specific gene expression changes reflecting neuron and oligodendrocyte loss and microglial activation. Earlier in the disease when integrated stress and innate immune responses are minimally induced, mature tRNA sequencing revealed a global reduction in tRNA levels and an altered tRNA profile but no changes in other Pol III transcripts. Thus, changes in the size and/or composition of the tRNA pool have a causal role in disease initiation. Our findings reveal different tissue- and brain region-specific sensitivities to a defect in Pol III transcription.